All In MedTech

FDA Clearance Tracker · P850009-S001

CA 125 ANTIBODY RIA

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 28, 1987 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 28, 1987

Approved

Time to decision

50 days

Received Jun 8, 1987. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class II

The decision

FDA number
P850009-S001
Device name
CA 125 ANTIBODY RIA
Applicant location
Malvern, PA
Received
Jun 8, 1987
Decided
Jul 28, 1987
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Other
Original approval
P850009

Device type

Device class
Class II
Regulation
21 CFR 866.6010

Every decision under product code LTK

Source documents

Other decisions for Centocor, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.